Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Automated Breast Ultrasound Systems (ABUS) - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Automated Breast Ultrasound Systems (ABUS) was estimated at US$852.1 Million in 2023, and is projected to reach US$2.0 Billion by 2030, growing at a CAGR of 13.3% from 2023 to 2030.
The growth in the Automated Breast Ultrasound Systems market is driven by several factors, including the rising global incidence of breast cancer, technological advancements in ultrasound imaging, and increasing awareness of the limitations of mammography in certain patient groups. As awareness of breast cancer screening increases, more women are seeking comprehensive screening solutions, particularly those who are identified as having dense breast tissue. Technological improvements in ABUS devices, such as enhanced imaging capabilities and the integration of AI, make these systems more appealing to healthcare providers by offering faster, more accurate readings and improving patient throughput.
In addition, there is a growing demand for non-radiation-based diagnostic alternatives, which positions ABUS as a favorable option compared to traditional mammography, especially for younger women or those at higher risk of breast cancer. Regulatory bodies and healthcare organizations are also increasingly recommending supplementary ultrasound screening for women with dense breasts, further driving adoption of ABUS in clinical practices worldwide. These trends highlight the dynamic expansion of the ABUS market, fueled by both technological innovations and changing healthcare practices.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Automated Breast Volume Scanner segment, which is expected to reach US$1.1 Billion by 2030 with a CAGR of a 13.2%. The Automated Breast Ultrasound System segment is also set to grow at 13.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $232.1 Million in 2023, and China, forecasted to grow at an impressive 17.8% CAGR to reach $450.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Automated Breast Ultrasound Systems (ABUS) Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Automated Breast Ultrasound Systems (ABUS) Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Automated Breast Ultrasound Systems (ABUS) Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Canon Medical Systems Corporation, Delphinus Medical Technologies, Inc., Esaote SPA, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 270 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $852.1 Million |
| Forecasted Market Value (USD) by 2030 | $2000 Million |
| Compound Annual Growth Rate | 13.3% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- World Market Trajectories
- Global Economic Update
- Automated Breast Ultrasound Systems (ABUS) - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Increasing Prevalence of Breast Cancer Throws the Spotlight On Early Detection Technologies like ABUS
- Rising Acceptance of ABUS in Cancer Screening Programs Expands Addressable Market
- Improved Imaging Capabilities of ABUS Strengthen the Business Case for Adoption
- Growing Healthcare Expenditure in Emerging Markets Drives ABUS Adoption
- Integration of AI in Ultrasound Systems Sets the Stage for Enhanced Detection Rates
- Advances in 3D Imaging Technology Propel the Use of ABUS
- The Growing Role of Women's Health Clinics in ABUS Deployment Expands Market
- Insurance Coverage Expansion for Advanced Ultrasound Systems Drives Market Adoption
- Technological Convergence Between Ultrasound and Other Imaging Modalities Throws the Spotlight On Hybrid Systems
- Cost-Effective ABUS Solutions Generate Demand in Cost-Sensitive Markets
- Rising Geriatric Population and Increased Breast Cancer Risk Propel Demand for Routine Screening with ABUS
FOCUS ON SELECT PLAYERS (Total 86 Featured):
- Canon Medical Systems Corporation
- Delphinus Medical Technologies, Inc.
- Esaote SPA
- GE HealthCare
- Hologic, Inc
- Mindray DS USA, Inc.
- Planmed Oy
- QView Medical
- Samsung Healthcare
- Siemens Healthineers NV/SA
- SonoCine, Inc
For more information about this report visit https://www.researchandmarkets.com/r/6p7n7u
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
